Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Perrotte

Showing results (101-110 of 245) with videos related to

Pageof 25
Sort By:
The Journal of Urology|December 20, 2011
Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomyMaxine Sun, Marco Bianchi, Quoc-Dien Trinh, et al.
BJU International|May 9, 2013
An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysisMarco Bianchi, Andreas Becker, Quoc-Dien Trinh, et al.
BJU International|January 29, 2014
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysisGiorgio Gandaglia, Maxine Sun, Quoc-Dien Trinh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapyLance C Pagliaro, Afsaneh Keyhani, Dallas Williams, et al.
European Urology|November 13, 2007
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 menClaudio Jeldres, Nazareno Suardi, Jochen Walz, et al.
European Urology|November 2, 2010
Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysisMaxine Sun, Rodolphe Thuret, Firas Abdollah, et al.
Cancer|September 16, 2008
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic featuresNazareno Suardi, Umberto Capitanio, Felix K H Chun, et al.
BJU International|December 17, 2008
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based studyUmberto Capitanio, Vincent Cloutier, Laurent Zini, et al.
Annals of Surgical Oncology|February 11, 2012
Treatment management of small renal masses in the 21st century: a paradigm shiftMaxine Sun, Firas Abdollah, Marco Bianchi, et al.
BJU International|May 23, 2012
Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbiditiesMaxine Sun, Marco Bianchi, Quoc-Dien Trinh, et al.
Pageof 25

Showing results (101-110 of 245) with videos related to

Sort By:
Pageof 25
The Journal of Urology|December 20, 2011
Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomyMaxine Sun, Marco Bianchi, Quoc-Dien Trinh, et al.
BJU International|May 9, 2013
An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysisMarco Bianchi, Andreas Becker, Quoc-Dien Trinh, et al.
BJU International|January 29, 2014
Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysisGiorgio Gandaglia, Maxine Sun, Quoc-Dien Trinh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2003
Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapyLance C Pagliaro, Afsaneh Keyhani, Dallas Williams, et al.
European Urology|November 13, 2007
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 menClaudio Jeldres, Nazareno Suardi, Jochen Walz, et al.
European Urology|November 2, 2010
Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysisMaxine Sun, Rodolphe Thuret, Firas Abdollah, et al.
Cancer|September 16, 2008
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic featuresNazareno Suardi, Umberto Capitanio, Felix K H Chun, et al.
BJU International|December 17, 2008
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based studyUmberto Capitanio, Vincent Cloutier, Laurent Zini, et al.
Annals of Surgical Oncology|February 11, 2012
Treatment management of small renal masses in the 21st century: a paradigm shiftMaxine Sun, Firas Abdollah, Marco Bianchi, et al.
BJU International|May 23, 2012
Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbiditiesMaxine Sun, Marco Bianchi, Quoc-Dien Trinh, et al.
Pageof 25